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Summary.-Procarbazine has been shown to be a hypoxic cell sensitizer of moderate
ability in E. coli B/r, withanachievable enhancement ratioof1-4atsubtoxic concentra-
tions. The drug appears to act in a manner similar to thatexpected with the electron-
affinic radiosensitizers. However, procarbazine and the electron-affinic sensitizers
differ in two important respects. Unlike the electron-affinic sensitizers, procarbazine
is not easily reduced, but is easily oxidized. It is more toxic to aerobic than to hypoxic
cells. At the drug dosages in present clinical use, procarbazine is likely to be only a
weak radiosensitizer. The possible implications of the data for the further develop-
ment of a new class of sensitizers and combination therapy are discussed.
RECENT YEARS have seen the rapid CH3 H 0 H H
development ofhypoxic cell sensitizers for 11 -=I I
use in radiotherapy. Such sensitizers offer H-C-N-C C C2-N-N-CH3.HCl
the hope of improved local control of
tumours in which a fraction of resistant, CH3 (1) Procarbazine
hypoxic cells is maintained throughout
the treatment schedule. Electron-affinic
compounds, such as the nitro-heterocyclic CH3 H O 'I, compounds metronidazole and misonid- 1I
azole, have emerged as likely candidates H-C-N-CCCH2NNN -CH3HCI
for clinical use, and trials are now in pro-
gress (Urtasun et al., 1976; Thomlinson et CH3
al., 1976). The :nitro-heterocyclic sensi- (Ix) AzoDerivative
tizers have been shown to be preferentially
toxic to hypoxic cells (Hall & Roizin-
Towle, 1975; Mohindra & Rauth, 1976; procarbazine can be regarded as a deriva-
Stratford & Adams, 1977). This finding tive ofmethyl hydrazine, itselfa radiation
coincides with a growing awareness of the sensitizer (Moroson & Spielman, 1966).
potential of combined-modality treat- Clinical use of procarbazine during radio-
ments. therapy has already been made. Claims
Procarbazine (I) is a cytotoxic agent for a therapeutic advantage over radiation
used singly or in combination, principally alone have been advanced (Sandison et al.,
in the treatment of Hodgkin's disease 1967; Falkson et al., 1970) and denied
(Spivak, 1974). It contains an aromatic (Landgren et al., 1973). It was felt that a
ketone grouping (see I), which formed the fundamental study of the toxicity and
basis on which several of the original sensitizing properties of procarbazine
electron-affinic sensitizers were chosen might clarify the potential of this com-
(Adams & Cooke, 1969). Alternatively, pound as a radiation sensitizer.
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MATERIALS AND METHODS
Overnight cultures of E. coli B/r grown at
37°C in tryptone-glucose-yeast (TGY)
medium were re-inoculated into fresh medium
and allowed to grow to late log phase. The
cells were filtered and washed in buffer (66mMi
phosphate salts at pH 7-0+0-1) and re-
suspended in a little buffer. Unless otherwise
stated a final suspension in buffer (107 eells/
ml) was made about 40 min after the cells
were harvested. Survival after exposure to
irradiation or procarbazine was determined
by dilution into buffer, followed by plating
out on TGY-agar and overnight incubation at
37°C. Most experiments were carried out at
room temperature (about 22°C) but a few
toxicity experiments were performed at
37°C. In both the irradiation and toxicity
experiments, either moist air or N2 (<12
parts/106 02 as determined in the effluent gas
by Hersch-cell measurement) wNas passed con-
tinuously through the suspension. Irradia-
tions were carried out in a Gammacell
220 60Co source at a dose rate of about
11 krad/min.
Procarbazine and misonidazole were used
as supplied by Roche Products (New Zealand)
Ltd and metronidazole as supplied by May
and Baker (New Zealand) Ltd. p-Nitro-
acetophenone and nifuroxime were obtained
from Koch-Light and Aldrich Chemicals
respectively. Menadione was supplied by Dr
Winterbourn, Christchurch Clinical School.
Polarographic half-wave potentials were de-
termined using deoxygenated 1mM procarb-
azine solutions in buffer at pH 7 and a PAR
174A polarographic analyser. The reference
electrode was a saturated calomel electrode
(SCE). Analytical TLC was performed using
Merck Kiesel gel 60F254 at a thickness of
0-25 mm and developed in methanol.
RESULTS AND DISCUSSION
Toxicity ofprocarbazine
Fig. 1 indicates that procarbazine is
preferentially toxic to E. coli B/r under
aerobic conditions. Increasing the tem-
perature from 22°C to 37°C gave a further
slight protection to hypoxic cells but
markedly increased the initial toxicity in
air. Hence the preferential toxicity to-
wards aerobic cells is enhanced at the














Fic.. 1. The toxicity of Imm procarbazine
towards E. coli B/r. Open symbols at 220C,
closed symbols at 37°C. Cells in N2 (O, *),
in air (J1, *) and transferred from air to
N2 after lh contact (A). The upper broken
line indicates survival in buffer alone at
22°C. Error bars (±s.e.) are within the
size of the data points.
that at 37°C the rate of cell killing in air
eventually decreased, until after 1 h con-
tact time the rate was less than t hat found
at 22°C. In one experiment the time
between the resuspension of the harvested
cells in buffer and the initial exposure to
procarbazine was varied between 0 and
3 h. Toxicity was strongly dependent upon
the elapsed time, decreasing with time.
The results suggest that active aerobic
metabolism is essential to the cytotoxic
action of procarbazine in E. coli B/r. The
in vivo mechanism of action of the drug is
still unknown, but it is noteworthy that
procarbazine is known to be rapidly
metabolized to the oxidized azo compound
II. Procarbazine has been found to de-
polymerize DNA in vitro only in the
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presence of oxygen. Reviews pertinent to
the in vivo and in vitro action of pro-
carbazine can be found in the Proceedings
of the Chemotherapy Conference on Pro-
carbazine: Development and Application
(ed. by S. K. Carter, Natl Cancer Inst.,
1970).
Radiation sensitization by procarbazine
The duration of exposure to the drug
was no more than 20 min in the following
experiments and, at the highest concentra-
tions reported, drug toxicity reduced sur-
vival by less than 20%. The Do values for
aerobic and hypoxic cells in the absence of
drug were 6 9 (p0 9) krad and 19*3 (11I0)
krad respectively (Fig. 2). Procarbazine
had no effect on the survival of E. coli B/r
when present during the irradiation of
aerobic cells, but sensitized hypoxic cells
(Fig. 2). Sensitization was purely dose-
modifying, and did not occur unless pro-
carbazine was present at the time of
irradiation. Enhancement ratios of 1.15,
1-25 and 1-4 were found for procarbazine
concentrations of 0'25 mm, 0 50 mm and
1 mM respectively. These enhancements
should be compared with an oxygen en-
hancement ratio (OER) of 2-8 in the same
system and enhancements for some nitro-
heterocyclic sensitizers of 1.9 for 0-25mm
nifuroxime, 1.3 for 1mM metronidazole and
16 for 1mM misonidazole. Considerably
higher enhancements can be achieved
with metronidazole and misonidazole,
since they do not become toxic until
far higher concentrations have been
attained.
Thus procarbazine is not a particularly
efficient hypoxic cell sensitizer, but the
result may be significant in view of the
established clinical use of the drug. Find-
ings that may militate against its straight-
forward use as a sensitizer are the short
half-life in human plasma (about 10 min;
Oliverio, 1970), the high tissue concentra-
tions that this study would indicate to be
necessary for a relatively small enhance-
ment, and the potential carcinogenicity of
procarbazine (Anderson, 1976). More par-










FIG. 2. The survival curves for E. coli B/r
irra(liated in N2 (0), in N2+05mM pro-
carbazine (0*), in air (LCi) and in air+
05mmt procarbazine (*). Error bars (±
s.e.) are within the size of the (data points.
out in which the irradiated cells were sus-
pended in growth medium (minus glucose)
instead ofbuffer. Do values in both air and
N2 were increased about 20%o over the
values in buffer. Thus the OER was not
significantly affected by growth medium.
However, the enhancement ratio for 1mm
procarbazine was reduced from 1.4 in
buffer to 1 1 in growth medium.
Two groups have used procarbazine as
an adjunct to radiotherapy. In a ran-
domized study ofbronchogenic carcinoma,
Landgren et al. (1973) found no beneficial
effect of a combined treatment. This was
in contrast to an earlier South African
study in which a significant (P 0.15) in-
crease in one year survival was claimed
(Sandison et al., 1967). In the latter study
the irradiation schedule was different in
the test and control groups. The South
African workers also reported that pro-
carbazine brought about an objective im-
provement in the radiation treatment of
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malignant melanomas and mesotheliomas
(Falkson et al., 1970). In the trials, doses
of procarbazine were in the range 50-450
mg/day. The results presented above indi-
cate that, unless procarbazine is a more
effective sensitizer of mammalian cells
than of bacteria, or is concentrated in
tumour tissue, far higher dosages than the
100 mg/M2 used in normal clinical practice
would be required to achieve a useful
enhancement of radiation effects.
Redoxproperties ofprocarbazine
The nitro-aromatic hypoxic cell sensi-
tizers of current interest for their applica-
tion to therapy evolved from an initial
theory that such sensitizers acted by virtue
oftheir electron affinity (Adams & Dewey,
1963; Adams & Cooke, 1969). It has been
established that the efficiency of a sensi-
tizer and its aerobic cytotoxicity are
directly related to its one-electron reduc-
tion potential at pH 7 (E71). The more
positive is E71, the greater is the efficiency
and toxicity ofthe sensitizer (Adams et al.,
1 976a, b). Procarbazine has a chemical
structure reminiscent ofthe early electron-
affinic sensitizers. Itsredox properties have
not been reported and have been inferred
in this work polarographically. Polaro-
graphy can only be a rough guide to redox
properties, but the results were quite clear.
A fresh solution of procarbazine was not
reduced at a potential more positive than
- 1500 mV, the limiting negative potential
in our system. Oxidation occurred at a
half-wave potential of about 100 mV.
This relatively easy polarographic oxida-
tion is consistent with the known aerobic
and in vivo oxidation of procarbazine to
Compound II (Oliverio, 1970).
In view of the ability of procarbazine
to sensitize hypoxic cells selectively, it is
perhaps surprising that procarbazine has
such a low electron affinity (i.e., it cannot
be easily reduced). It is pertinent to ask
whether it is an oxidation product of pro-
carbazine that is the true sensitizing agent.
Two types of experiment were performed
in an attempt to answer this question.
Firstly, cells were exposed to a fresh pro-
carbazine solution under aerobic condi-
tions for 1 h. The cells and the solution
were then separated. Irradiation of the
procarbazine-exposed cells in buffer and
under hypoxia showed that only a very
slight enhancement (<1I1) could be ob-
served. This may not be significant, and
could be due to carry-over of intracellular
procarbazine. It was shown that the
separated solution had a similar sensitizing
ability to a procarbazine solution which
had not been pre-exposed to cells. Second-
ly, the sensitizing ability of a Imm pro-
carbazine solution was followed as the
solution was allowed to oxidize on stand-
ing in air. No significant change in sensi-
tizing ability was noted over the first few
days, and on about Day 4 the solution
became excessively toxic. During this
latter experiment the oxidative degrada-
tion of the procarbazine solution was
followed by analytical thin-layer chroma-
tography and polarographically. The pro-
carbazine was initially chromatographic-
ally pure. Within 1 h of making up a
solution, a species capable of reduction at
a half-wave potential of about 600 mV
could be detected. This species could be
Compound II. The published data (e.g.
Greenstock et al., 1976; Adams et al.,
1976a) suggest that compounds with a
reduction potential as negative as 600
mV will be, at best, very inefficient
sensitizers. In the time scale of the usual
irradiation experiments, the amount of
any oxidation products was less than 1%
ofthe original procarbazine concentration,
according to TLC analysis. A significant
contribution to sensitization from the
production of reducible species as the
solution ages appears unlikely. Both
polarography and TLC indicated that the
subsequent further degradation of pro-
carbazine was complex. No species with
more positive half-wave reduction poten-
tials than 600 mV were detected. The
above data imply that it is procarbazine
itself which causes the sensitization of
irradiated hypoxic cells. However, it is
conceded that only a crude assessment of
any contribution from the intracellular
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degradation of procarbazine was possible.
Intracellular processes may be both more
rapid and different from those monitored
in the experiments outlined above and a
contribution from such processes cannot
be entirely ruled out.
Conmparison with other work
The relationships between E71, sensi-
tization and toxicity for electron-affinic
sensitizers referred to above have been
established recently using mammalian
cells (Adams et al., 1976a, b). To assess the
present results more fully, it was necessary
to establish that the same relationships
apply in our bacterial system. The Table
TABLE.-The relationship between E71, sen-
sitiziny ability and aerobic toxicity in E.








Menadiolle -203 0015 1 4 at 0 15m1r
Nifuroxime -253 2 1*9 at 0*25mM
p-Nitro-
acetophenone -355 2 1-6 at 1mmt
M\isonidazole -389 10 1-6 at 1mM
Metronidazole -486 50 1-3 at ImM
* Values from Adams et al. (1976b).
t Defined as the concentration required to reduce
survival to the 0-1 level after 2h contact.
demonstrates this to be the case. Sensi-
tizing ability and aerobic toxicitygenerally
increase with more positive E71 values, the
only exception being the similar toxicity
of p-nitroacetophenone and nifuroxime.
The nitro-heterocyclic sensitizers have
been found to exhibit preferential cyto-
toxicity towards hypoxic mammalian cells
(Hall & Roizin-Towle, 1975; Mohindra &
Rauth, 1976; Stratford & Adams, 1977).
A similar effect in E. coli B/r was found
during this work (Fig. 3).
CONCLUSIONS
Procarbaziine is capable of the radiation
sensitization of hypoxic cells. The en-
hancements achieved at concentrations













FIG. 3. The toxicity of 2m-m nifuroxime to-
wards E. coli B/r at 22°C in air (0) and in
N2 (0). Error bars (± s.e.) are within the
size of the data points.
are modest, however, and the clinical
relevance of this finding is uncertain at
present.
Of more interest are the implications of
this study for the further development of
hypoxic cell sensitizers and for combina-
tion chemotherapy/radiotherapy. Procarb-
azine shows clear differences when com-
pared with the nitro-heterocyclic radio-
sensitizers on which attention has been
focused. It is not easily reduced, but
easily oxidized (i.e., it tends to donate
rather than accept electrons). Like the
nitro-heterocyclic compounds, procarb-
azine is a selective hypoxic cell radio-
sensitizer; however, it is more toxic to
aerobic than to hypoxic cells. Careful
delineation of the selective toxic and
radiosensitizing properties ofany drug pro-
posed for use in conjunction with radio-
therapy is indicated. One of the theories
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advanced to account for the selective
toxicity of the nitro-heterocyclic com-
pounds invokes interference with electron-
transport processes (Adams et al., 1976b).
The fact that procarbazine, which is
electron-donating rather than electron-
withdrawing, exhibits selective toxicity
which is the reverse ofthat found with the
nitro-heterocyclics may lend support to
the electron-transport theory.
Ifit is accepted that procarbazine itself
and not an oxidation product acts as the
sensitizing agent, a comment relevant to
the mechanism of sensitization can be
made. Electron-affinic, hypoxic cell sensi-
tizers are thought to enhance radiation
damage by promoting electron withdrawal
from a damaged target site (Adams, 1972).
It is tempting to speculate that procarb-
azine acts by electron donation, i.e. in a
complementary fashion to the electron-
affinic compounds. However, it has been
suggested (Lohman, 1974) that electron
donation will result in radiation protection
rather than sensitization. The protective
influence of oxidizable compounds such as
sulphydryl and related chemicals (Adams,
1972; Pihl & Sanner, 1970) would support
such a suggestion. Procarbazine may be a
unique sensitizing agent. However, if ease
of oxidation can be associated with
hypoxic cell sensitization under certain
conditions, the examination of compounds
with a range of oxidation potentials may
suggest a fresh class of potentially useful
radiosensitizers.
I am grateful for the co-operation of Dr P. T.
Wilson and Dr A. D. Woolhouse of the Chemistry
Division of DSIR in the polarographic and TLC
measurements.
REFERENCES
ADAMS, G. E. (1972) Radiation chemical mech-
anisms in radiation biology. Adv. Radiat. Chem., 3,
125.
ADAMS, G. E. & COOKE, M. S. (1969) Electron-
affinic sensitization. 1. A structural basis for
chemical radiosensitizers in bacteria. Int. J.
Radiat. Biol., 15, 457.
ADAMS, G. E. & DEWEY, D. L. (1963) Hydrated
electrons and radiobiological sensitization. Bio-
chem. Biophys. Res. Comm., 12, 473.
ADAMS, G. E., FLOCKHART, I. R., SMITHEN, C. E.,
STRATFORD, I. J., WARDMAN, P. & WATTS, M. E.
(1976a) Electron-affinic sensitization. VII. A
correlation between structures, one-electron re-
duction potential, and efficiencies of nitroimid-
azoles as hypoxic cell radiosensitizers. Radiat. Res.,
67, 9.
ADAMS, G. E., CLARKE, E. D., JACOBS, R. S. & 4
others (1976b) Mammalian cell toxicity of nitro
compounds: dependence upon reduction poten-
tial. Biochem. Biophy8. Res. Comm., 72, 824.
ANDERSON, R. H3. (1976) Chemical carcinogensis and
biological markers in non-human primates. J. Med.
Primatol., 4, 337.
FALKSON, G., FALKSON, H. C. & FICHARDT, T. (1970)
Radiosensitization by procarbazine in the treat-
ment of malignant mesothelioma. In Radiation
Protection and Sensitization. Ed. H. L. Moroson
& M. Quintiliani. London: Taylor & Francis. p. 499.
GREENSTOCK, C. L., RUDDOCK, G. W. & NETA, P.
(1976) Pulse radiolysis and ESR studies of the
electron-affinic properties of nitroheterocyclic
radiosensitizers. Radiat. Res., 66, 472.
HALL, E. J. & RoIzIN-TOWLE, L. (1975) Hypoxic
sensitizers: radiobiological studies at the cellular
level. Radiology, 117, 453.
LANDGREN, R. C., HusSEY, D. H., SAMUELS, M. L.
& LEARY, W. V. (1973) A rarLdomized study com-
paring irradiation alone to irradiation plus pro-
carbazine in inoperable bronchogenic carcinoma.
Radiology, 108, 403.
LOHMANN, W. (1974) The molecular mechanism of
radiation protection and sensitization. In Advances
in Chemical Radiosen8itization. Vienna: IAEA.
p. 115.
MOHINDRA, J. K. & RAUTH, A. M. (1976) Increased
cell killing by metronidazole and nitrofurazone of
hypoxic compared to aerobic mammalian cells.
Cancer Res., 36, 930.
MOROSON, H. & SPIELMAN, H. A. (1966) Chemical
sensitization of mice to lethality. Int. J. Radiat.
Biol., 11, 87.
OLIVERIO, V. T. (1970) Pharmacologic disposition of
procarbazine. In Proceedings of the Chemotherapy
Conference on Procarbazine: Developmemn and
Application. Ed. S. K. Carter. Natl Cancer In8t.,
P. 19.
PIHL, A. & SANNER, T. (1970) Chemical protection
against ionizing radiation by sulphur-containing
agents. In Radiation Protection and Sensitization.
Eds. H. L. Moroson & M. Quintiliani. London:
Taylor & Francis. p. 43.
SANDISON, A. G., FALKSON, G., FICHARDT, T. &
SAVAGE, D. J. (1967) A statistical evaluation of
the treatment of 215 patients with advanced
bronchial cancer managed by telecobalt therapy
alone, and in combination with various cancer
therapeutic agents. S. African J. Radiol., 5, 21.
SPIVAK, S. D. (1974) Procarbazine. Ann. Int. Med.,
81, 795.
STRATFORD, I. J. & ADAMS, G. E. (1977) Effect of
hyperthermia on differential cytotoxicity of a
hypoxic cell radiosensitizer, Ro-07-0582, on mam-
malian cells in vitro. Br. J. Cancer, 35, 307.
THOMLINSON, R. H., DISCHE, S., GRAY, A. J. &
ERRINGTON, L. M. (1976) Clinical testing of the
radiosensitizer Ro-07-0582. III. Response of
tumours. Clin. Radiol., 27, 167.
URTASUN, R., BAND, P., CHAPMAN, J. D., FELDSTEIN,
M. L., MIELKE, B. & FRYER, C. (1976) Radiation
and high dose metronidazole (Flagyl) in supra-
tentorial glioblastomas. N. Engl. J. Med., 294,
1364.